JAY ENDRES: Open Payments
NPI 1073581948 · WARREN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 40 payments from 14 companies in 2025. Trend: 2023 $472 · 2024 $373 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $249 |
| PFIZER INC. | 6 | $101 |
| GlaxoSmithKline, LLC. | 6 | $95 |
| Exact Sciences Corporation | 5 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Novo Nordisk Inc | 3 | $48 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Verona Pharma, Inc. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: BREZTRI, TRELEGY ELLIPTA, ELIQUIS, REXULTI, AIRSUPRA, Cologuard Collection Kit, Ozempic, FARXIGA.
Industry payments across PA — which companies pay providers there.
